发明名称 GEM-SUBSTITUTED HYDROXAMIC ACID
摘要 PROBLEM TO BE SOLVED: To provide a geminally disubstituted cyclic hydroxamic acid derivative effective for the therapy of arthritis, cancer and other diseases. SOLUTION: This compound is represented by general formula (I) or a pharmaceutically acceptable salt thereof. Concretely, 4-[4-(4-fluoro-2-methyl- benzyloxy)-benzenesulfonyl]-3-hydroxy-tetrahydro-pyrane-3-carboxylic acid hydroxamide is cited as the compound. The compound represented by general formula (I) has activities for inhibiting matrix metalloprotease and an enzyme belonging to the reprolysin subfamily of metzincins, and exhibits therapeutic effects on the wide diseases including the above diseases.
申请公布号 JP2001316383(A) 申请公布日期 2001.11.13
申请号 JP20010095089 申请日期 2001.03.29
申请人 PFIZER PROD INC 发明人 NOE MARK CARL
分类号 C07D211/60;A61K31/351;A61K31/4427;A61K31/443;A61K31/445;A61K31/4523;A61P1/00;A61P1/02;A61P1/04;A61P3/00;A61P3/10;A61P7/00;A61P9/00;A61P9/02;A61P9/04;A61P9/10;A61P11/00;A61P11/06;A61P17/02;A61P19/00;A61P19/02;A61P19/10;A61P25/00;A61P25/04;A61P25/06;A61P25/14;A61P25/16;A61P25/24;A61P25/28;A61P27/02;A61P29/00;A61P31/00;A61P35/00;A61P35/04;A61P37/00;A61P37/02;A61P37/08;A61P43/00;C07D211/96;C07D309/08;C07D309/10;C07D309/14;C07D401/12;C07D405/12;C07D405/14;(IPC1-7):C07D309/10;A61K31/442;A61K31/452 主分类号 C07D211/60
代理机构 代理人
主权项
地址